home / stock / grcl / grcl quote
Last: | $10.25 |
---|---|
Change Percent: | -0.1% |
Open: | $10.26 |
Close: | $10.25 |
High: | $10.28 |
Low: | $10.17 |
Volume: | 6,417,173 |
Last Trade Date Time: | 02/21/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$10.25 | $10.26 | $10.25 | $10.28 | $10.17 | 6,417,173 | 02-21-2024 |
$10.245 | $10.2 | $10.245 | $10.27 | $10.175 | 1,957,462 | 02-20-2024 |
$10.14 | $10.23 | $10.14 | $10.23 | $10.09 | 2,172,771 | 02-19-2024 |
$10.14 | $10.23 | $10.14 | $10.23 | $10.09 | 2,172,771 | 02-16-2024 |
$10.17 | $10.26 | $10.17 | $10.29 | $10.15 | 924,720 | 02-15-2024 |
$10.27 | $10.35 | $10.27 | $10.35 | $10.265 | 548,341 | 02-14-2024 |
$10.34 | $10.24 | $10.34 | $10.365 | $10.22 | 641,558 | 02-13-2024 |
$10.26 | $10.3 | $10.26 | $10.35 | $10.23 | 348,369 | 02-12-2024 |
$10.35 | $10.2 | $10.35 | $10.435 | $10.19 | 1,752,582 | 02-09-2024 |
$10.23 | $10.18 | $10.23 | $10.25 | $10.18 | 441,904 | 02-08-2024 |
$10.23 | $10.19 | $10.23 | $10.245 | $10.17 | 203,368 | 02-07-2024 |
$10.24 | $10.18 | $10.24 | $10.25 | $10.18 | 332,466 | 02-06-2024 |
$10.21 | $10.18 | $10.21 | $10.21 | $10.115 | 512,362 | 02-05-2024 |
$10.21 | $10.16 | $10.21 | $10.25 | $10.16 | 342,220 | 02-02-2024 |
$10.23 | $10.18 | $10.23 | $10.3 | $10.18 | 846,400 | 02-01-2024 |
$10.22 | $10.1 | $10.22 | $10.33 | $10.1 | 2,098,926 | 01-31-2024 |
$10.16 | $10.15 | $10.16 | $10.22 | $10.09 | 898,836 | 01-30-2024 |
$10.18 | $10.06 | $10.18 | $10.205 | $10.06 | 1,828,396 | 01-29-2024 |
$10.06 | $10.12 | $10.06 | $10.13 | $10.05 | 146,770 | 01-26-2024 |
$10.06 | $10.06 | $10.06 | $10.22 | $10.04 | 2,227,800 | 01-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Gracell Biotechnologies Inc. Company Name:
GRCL Stock Symbol:
NASDAQ Market:
Gracell Biotechnologies Inc. Website:
Volcon Inc. (VLCN) is expected to report for Q4 2023 Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31 Hesai Group (HSAI) is expected to report for Q4 2023 Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023 Eliem Therapeutics Inc (ELYM) i...
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell ...
Gracell Biotechnologies Inc. (NASDAQ: GRCL) is the focus of IBN's latest stock spotlight. The company's shares have moved -0.49% on the day to $10.19. Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of ...